Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125492231 | 12549223 | 1 | I | 20160214 | 20160707 | 20160712 | 20160712 | EXP | CN-PFIZER INC-2016335052 | PFIZER | 58.00 | YR | M | Y | 0.00000 | 20160712 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125492231 | 12549223 | 1 | PS | VFEND | VORICONAZOLE | 1 | Intravenous drip | 200 MG, 2X/DAY | 1800 | MG | Z331201 | 21267 | 200 | MG | POWDER FOR SOLUTION FOR INFUSION | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125492231 | 12549223 | 1 | Lung infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125492231 | 12549223 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125492231 | 12549223 | Cognitive disorder | |
125492231 | 12549223 | Hallucination, auditory | |
125492231 | 12549223 | Hallucination, visual | |
125492231 | 12549223 | Halo vision | |
125492231 | 12549223 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125492231 | 12549223 | 1 | 20160208 | 20160212 | 0 |